
[email protected]
Corey Casper
Chief Medical Officer at the Infectious Disease Research Institute
Corey Casper joined the Infectious Disease Research Institute (IDRI) as its Chief Medical Officer in May 2017. Prior to joining the IDRI, Casper worked at Fred Hutchinson Cancer Research Center and the University of Washington, with extensive experience leading multi-phased international clinical trials from conception to publication to U.S. Food and Drug Administration (FDA) licensure. In his role as IDRI’s Chief Medical Officer, Corey is developing and leading all clinical trial programs for IDRI from preclinical to Phase III, including oversight and management of data functions.
Corey has more than 20 years of experience in designing, growing and sustaining internationally-recognized programs in infection-related cancers, HIV, infection control and global oncology. Corey served as a Full Member in the Vaccine and Infectious Disease, Clinical Research and Public Health Sciences Divisions at the Fred Hutchison Cancer Research Center where he founded and directed the one of the nation’s first and most effective outpatient infection control programs; he also founded and directed the first Global Oncology program at a designated comprehensive cancer center. At the University of Washington, Corey was appointed as a Professor of Medicine, Epidemiology and Global Health, and served as the Co-Director of the Center for AIDS Research. Corey has held several clinical positions, including serving as an attending physician for the Seattle Cancer Care Alliance’s Infectious Disease Consult Service.
Corey obtained an undergraduate degree in Biology from Wesleyan University, his MD from Cornell University Medical College and a Master of Public Health degree from the University of Washington.
Related Speakers View all
![]() |
Marty Makary, M.D.
Healthcare Futurist, Johns Hopkins Surgeon & Profess...
|
![]() |
Marcella Nunez-Smith
Chair of the COVID-19 Health Equity Task Force; Asso...
|
![]() |
Dr. Elizabeth Jaffee
International Leader in Immune Based Therapies for P...
|
![]() |
Dr. Laura Esserman
Surgeon & Breast Cancer Oncology Specialist at UCSF;...
|
![]() |
Leonard I. Zon
Cancer Genetics & Stem Cell Biology Researcher; Prof...
|
![]() |
Shekinah Elmore
Oncologist; Dedicated to Pursuing Equity & Empathy i...
|
![]() |
Ian Frazer
Immunologist; Co-Creator of HPV Vaccine; Founding CE...
|
![]() |
Barbara Bowers, MD
Medical Oncologist Specialized in the Diagnosis & Tr...
|
![]() |
Douglas Yee, MD
Director of the Masonic Cancer Center at the Univers...
|
![]() |
Andy Schmeltz
Global President and General Manager, Pfizer Oncology
|
![]() |
Tisha Rowe
Family Medicine Physician & Entrepreneur
|
![]() |
Yehia Abugabal
Founder & Director at International Cancer Research ...
|
![]() |
David Agus
Co-Founder of Navigenics, Author of "The End of Illn...
|
![]() |
Stephanie Lheureux
Clinician Investigator & Medical Oncologist at Princ...
|
![]() |
Nikhil Wagle
Director, Count Me In, Broad Institute
|
![]() |
Steven Burakoff
Dean for Cancer Innovation & Chief of Pediatric Hema...
|
![]() |
Katrina Armstrong
Chief Executive Officer of the Columbia University I...
|
![]() |
Josh Allen
Vice President of Research and Development at Oncoce...
|
![]() |
Laurie H. Glimcher
President & CEO of Dana-Farber Cancer Institute; Can...
|
![]() |
Dr. Joel Selanikio
Award-Winning Physician, Health & Technology Activis...
|